Log In
Print this Print this


Also known as: formerly VRS-808

  Manage Alerts
Collapse Summary General Information
Company Amunix Operating Inc.
DescriptionGlucagon attached to Amunix's recombinant XTEN technology
Molecular Target Glucagon receptor (GCGR)
Mechanism of ActionGlucagon receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat nocturnal hypoglycemia in diabetic patients; Treat Type II diabetes and obesity
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today